The stock of Rocket Lab USA Inc. (NASDAQ:RKLB) increased by $0.24 on Tuesday to finish at $6.17, up 4.05 percent. The last five days have seen an average of 2,626,080 shares of common stock traded. 19 times new highs were reached in the current year, with a gain of $2.40. The average number of shares traded over the last 20 days was 3,459,635, while the average volume over the last 50 days totaled 4,579,720.
RKLB stock dropped -16.28% since last month. On 08/18/23, the company’s shares reached a one-month low of $5.36. The stock touched a high of $8.05 on 07/19/23, after rallying from a low of $3.48 in 52 weeks. The price of RKLB stock has risen by 63.66% or $2.40 this year, reaching a new high 19 times. Still, the stock price is down -23.35% from the 52-week high.
Insider Transactions
RKLB stock investors should be aware that Rocket Lab USA Inc. (RKLB) stock had its last reported insider trading activity 5 days ago on Aug 25. On Aug 25, Chief Financial Officer Spice Adam C. sold 61,377 shares at $5.74 each. This transaction resulted in the insider making $352,525. On Aug 25, Kampani Arjun sold 20,675 shares at a price of US$5.74. After the transaction, the insider now owns 525,390 shares. Director GRIFFIN MICHAEL D had earlier sold 50,689 shares on Jun 06 for $5.00 a share. The transaction was completed for $253,445.
Valuation Metrics
Beta for the stock is 1.11. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 12.55, the price-to-book (PB) ratio of 4.86.
Financial Health
For the three months ended June 29, Rocket Lab USA Inc.’s quick ratio was 1.50, while its current ratio was 1.80, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.03, and the total debt to equity ratio is 0.20. As far as profitability goes, gross margin for the trailing twelve months is 13.50% percent. Rocket Lab USA Inc.’s EBITDA margin for the year ended June 29 was -51.48%, whereas its operating margin stood at -69.20% for the same period. Based on annual data, it had gross profit of $18.99 million and revenue of $211.0 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. RKLB’s return on assets (ROA) during the last 12 months has been -16.50%. There was a -17.40% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -25.00%.
Earnings Surprise
According to Rocket Lab USA Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $61.59 million, while revenues rose by 9.94% to $54.9 million. It was predicted that Rocket Lab USA Inc.’s quarterly earnings would be -$0.1, but it ended up being -$0.09, beating the consensus by -11.10%. EBITDA was -$37.69 million for the quarter. At the end of Rocket Lab USA Inc.’s most recent quarter ended June 29, its liabilities totaled 370.45 million, while its total debt was $162.94 million. Equity owned by shareholders amounts to $483.33 million.
Technical Picture
Here’s a quick look at Rocket Lab USA Inc.’s (RKLB) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 52.29%, suggesting the stock is Neutral, with a 62.69% historical volatility rate.
The stochastic %K and %D were 35.83% and 25.40% respectively, while the average true range (ATR) was 0.37. Based on the 14-day stochastic reading of 60.53%, the RSI (14) reading is 49.34%. On the 9-day MACD Oscillator, the stock is at 0.12.
Analyst Ratings
In its analyst report released on April 18, 2023, Citigroup began covering Rocket Lab USA Inc. (NASDAQ: RKLB). The stock was rated as a Neutral by the brokerage firm. Analysts have assigned Rocket Lab USA Inc. (RKLB) an Overweight rating. RKLB is a stock that is recommended for selling by 0 brokerage firms, while 2 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 6 others recommend it as a buy.
What is RKLB’s price target for the next 12 months?
The current consensus forecast for the stock is between $6.75 and $14.00, with a median target price of $10.00. In analyzing these forecasts, the average price target given by analysts for Rocket Lab USA Inc. (RKLB) is $9.83.
